Bharat Parenterals
- Company typePublic
- Founded1992
- HeadquartersVadodara, India
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
Bharat Parenterals firmographics
Firmographics- Name
- Bharat Parenterals
- Legal name
- Bharat Parenterals Limited
- Website
- https://bplindia.in
- Company type
- Public
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Bharat Parenterals industry classification
Industry- Product category
- Sterile Injectable Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Generic Hospital & Institutional Products (HLAIABAL)
Keywords
Where Bharat Parenterals is headquartered
LocationHeadquarters
- HQ city
- Vadodara
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
Bharat Parenterals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure
Bharat Parenterals product offering
Product offeringCore offering
Bharat Parenterals is a pharmaceutical manufacturer that produces sterile injectable formulations through its wholly-owned subsidiary Innoxel Lifesciences. The General Injectables Block in Vadodara, Gujarat manufactures finished dosage injectable products primarily for regulated markets including the United States and European Union. The company also completed an acquisition of Varenyam Healthcare in 2024, expanding its healthcare footprint.
Product overview
Bharat Parenterals is a pharmaceutical company operating as a platform with its Innoxel Lifesciences subsidiary. The subsidiary operates the General Injectables Block, a finished dosage manufacturing facility in Vadodara, Gujarat that produces sterile injectable formulations for regulated markets including the United States and European Union.
Differentiator
Problem solved
Functional benefit
Products and services
- Sterile Injectable Formulations Sterile injectable finished dosage drug products manufactured for regulated pharmaceutical markets including the United States and European Union.
- General Injectables Block Manufacturing (Innoxel Lifesciences) Finished dosage manufacturing facility operated by Innoxel Lifesciences in Vadodara, Gujarat that produces sterile injectable formulations, with USFDA-inspected compliance status.
Companies that use Bharat Parenterals
Customer profileIdeal customer profiles1 record
Bharat Parenterals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Bharat Parenterals partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Innoxel LifesciencescoreInnoxel Lifesciences is a subsidiary of Bharat Parenterals that underwent a USFDA inspection at its finished dosage manufacturing facility in Vadodara, Gujarat from April 13-17, 2026. The inspection concluded with five observations under a Voluntary Action Indicated (VAI) classification. This subsidiary operates the General Injectables Block which manufactures sterile injectable formulations for regulated markets including the United States and European Union.
Scale indicators3 records
Recent moves4 records
Expansion highlights3 records
Bharat Parenterals competitors and assessment
Company assessmentDirect peers
- Biological E: Indian specialty injectables and vaccines manufacturer with similar profile of supplying institutional and regulated customers with sterile injectable formulations. Direct comparable in product category and manufacturing focus.
- Gland Pharma: Indian pure-play sterile injectables manufacturer, also serving regulated US and EU markets. Gland Pharma is the closest direct comparable in product category, regulatory exposure, and customer base, though significantly larger in scale.
- Bharat Serums and Vaccines: Indian specialty injectables and biologicals manufacturer with similar therapeutic focus areas including sterile formulations for institutional/regulated markets, making it a direct comparable in product category and target segments.
Broad incumbents
- Cipla: Major Indian pharmaceutical company with sterile injectable manufacturing capabilities and global regulated market presence. Broad incumbent with overlapping injectable franchise but much more diversified across respiratory, HIV, and other therapeutic areas.
- Cadila Healthcare (Zydus): Indian pharmaceutical company with injectable manufacturing operations serving regulated markets. Broad incumbent with overlapping product capabilities in sterile injectables for US/EU but broader portfolio spanning generics, biosimilars, and consumer health.
- Lupin: Indian pharmaceutical manufacturer with injectable and complex generics portfolio. Broad incumbent with USFDA-approved manufacturing capabilities and significant presence in regulated markets, though diversified across multiple dosage forms.
- Aurobindo Pharma: Major Indian generic pharmaceutical manufacturer with significant USFDA-approved injectable manufacturing capacity. Broad incumbent with overlapping regulated-market injectable franchise but operates at much larger scale across multiple dosage forms.
- Dr. Reddy's Laboratories: Large Indian pharmaceutical company with a meaningful sterile injectables portfolio supplying US and EU regulated markets. A broad incumbent with overlapping capabilities but serving many additional therapeutic categories and dosage forms.
- Sun Pharmaceutical Industries: India's largest pharmaceutical company with sterile injectable manufacturing for global regulated markets. Broad incumbent that competes in similar institutional/regulated channels but is highly diversified across dosage forms and geographies.
Emerging players
- Hikal: Indian pharmaceutical manufacturer with capabilities in APIs and intermediates, increasingly moving into sterile injectables and specialty manufacturing. Emerging player with partial overlap in the regulated injectable space where Bharat Parenterals operates.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Bharat Parenterals social profiles
Digital presenceBharat Parenterals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bharat Parenterals leadership team
Management profileNumber of profiles
Profiles1 record
Bharat Parenterals subsidiaries and ownership
Company hierarchySubsidiaries1 record
Bharat Parenterals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bharat Parenterals M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bharat Parenterals
What does Bharat Parenterals do?
Bharat Parenterals is a pharmaceutical manufacturer that produces sterile injectable formulations through its wholly-owned subsidiary Innoxel Lifesciences. The General Injectables Block in Vadodara, Gujarat manufactures finished dosage injectable products primarily for regulated markets including the United States and European Union. The company also completed an acquisition of Varenyam Healthcare in 2024, expanding its healthcare footprint.
Is Bharat Parenterals a public or private company?
Bharat Parenterals is a public company. It is classified as public and is currently operating.
When was Bharat Parenterals founded?
Bharat Parenterals was founded in 1992. It employs 101 to 250 people.
Where is Bharat Parenterals based?
Bharat Parenterals is headquartered in Vadodara, India, in the Asia region.
Who are Bharat Parenterals's main competitors?
Direct peers on record are Biological E, Gland Pharma and Bharat Serums and Vaccines. Broad incumbents are Cipla, Cadila Healthcare (Zydus), Lupin, Aurobindo Pharma, Dr. Reddy's Laboratories and Sun Pharmaceutical Industries. Hikal is listed as an emerging player.
Does Bharat Parenterals have an API?
No public API is recorded for Bharat Parenterals.
What industry is Bharat Parenterals in?
Bharat Parenterals's product category is Sterile Injectable Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIABAL, Generic Hospital & Institutional Products. Its NAICS code is 325412 and its SIC code is 2834.